RayKnowChina Research Map
Shortlist

Chongqing Medical University

重庆医科大学

ChongqingUniversity or health system

Hospitals that carry this university's name, added together, plus papers and trials that name only the university.

Research activity, not treatment quality. Not medical advice. How this works

Nasopharyngeal carcinoma

鼻咽癌
0.4%Leads under 1 in 100 of China's research papers on NPC

Led 10 of 2,375 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (23.4%).

Run this PubMed search

Open trials led
0
Research papers it led
10
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.3%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 2220242025: 332025
ThemesInduction / concurrent chemotherapyRadiotherapy techniqueRecurrent / metastatic disease

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University8
  2. Second Affiliated Hospital of Chongqing Medical University Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Oesophageal squamous cell carcinoma

食管鳞状细胞癌
0.8%Leads under 1 in 100 of China's research papers on ESCC

Led 22 of 2,923 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (6.9%).

Run this PubMed search

Open trials led
0
Research papers it led
22
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.5%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 2220242025: 222025
ThemesImaging & AINeoadjuvant & combined treatmentImmunotherapy

Hospitals counted here

  1. Second Affiliated Hospital of Chongqing Medical University10
  2. First Affiliated Hospital of Chongqing Medical University7
  3. Third Affiliated Hospital of Chongqing Medical University3

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Hepatocellular carcinoma

肝细胞癌
1.5%Leads about 1 in 66 of China's research papers on HCC

Led 224 of 14,765 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (5.5%).

Run this PubMed search

Open trials led
1
Research papers it led
224
Trials it led
6
Share of China's trials
0.4%
Share of the world's papers
0.8%
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 3320242025: 112025
ThemesRecurrence & prognosisImaging, AI & early detectionHepatitis B & cirrhosis

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. Second Affiliated Hospital of Chongqing Medical University108
  2. First Affiliated Hospital of Chongqing Medical University64
  3. Children's Hospital of Chongqing Medical University Counted in the group total6
  4. Third Affiliated Hospital of Chongqing Medical University Counted in the group total4
  5. Bishan Hospital, Chongqing Medical University Counted in the group total3
  6. Yongchuan Hospital, Chongqing Medical University Counted in the group total2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.2021Frontiers in public healthRCTFree full text
  2. Phosphoglycerate dehydrogenase stabilizes protein kinase C delta type mRNA to promote hepatocellular carcinoma progression.2025Signal transduction and targeted therapyFree full text
  3. Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial.2024Lancet (London, England)
  4. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.2024Lancet (London, England)
  5. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B: still needs further discussion.2024Gut
Trials on ClinicalTrials.gov6
  1. Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical StudyNot yet recruitingNCT07324473Lead sponsorPhase 2Start 2026-01
  2. Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular CarcinomaNot yet recruitingNCT07866612Study siteN/AStart 2026-12
  3. ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 OverexpressionRecruitingNCT07327034Study sitePhase 2Start 2025-06
  4. Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular CarcinomaStatus unknownNCT05670561Lead sponsorPhase 4Start 2023-01
  5. Auxiliary Diagnosis of Liver Nodules Using cfDNA Whole-genome SignaturesStatus unknownNCT05393102Lead sponsorStart 2022-05
  6. Effect of Nutritional Indices on the Prognosis of HCC PatientsCompletedNCT05635279Lead sponsorStart 2022-11

PubMed searchClinicalTrials.gov

Stomach cancer

胃癌
0.8%Leads under 1 in 100 of China's research papers on Stomach cancer

Led 77 of 9,782 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (3.9%).

Run this PubMed search

Open trials led
0
Research papers it led
77
Trials it led
6
Share of China's trials
0.4%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 1120242025: 442025
ThemesSurgeryEarly detection & endoscopyPeritoneal spread & advanced disease

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University35
  2. Second Affiliated Hospital of Chongqing Medical University23
  3. Yongchuan Hospital, Chongqing Medical University Counted in the group total2
  4. Children's Hospital of Chongqing Medical University Counted in the group total2
  5. Third Affiliated Hospital of Chongqing Medical University Counted in the group total2
  6. First People's Hospital, Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. Application of dexmedetomidine combined with propofol-etomidate mixture in radical gastrectomy under general anesthesia.2024MedicineRCTFree full text
  2. Linked color imaging for detection and characterization of gastrointestinal neuroendocrine tumors.2025BMC gastroenterologyFree full text
  3. Gastric Adenocarcinoma Resembling Submucosal Tumor: A Case Report.2025The American journal of case reportsFree full text
  4. Safety and efficacy of laparoscopic radical gastrectomy after neoadjuvant chemotherapy plus immunotherapy: a retrospective cohort study.2025Frontiers in immunologyFree full text
  5. Association between the red blood cell distribution width-to-albumin ratio and risk of colorectal and gastric cancers: a cross-sectional study using NHANES 2005-2018.2025BMC gastroenterologyFree full text
Trials on ClinicalTrials.gov6
  1. Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT07385703Study sitePhase 3Start 2026-04
  2. A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerRecruitingNCT06532006Study sitePhase 3Start 2024-11
  3. A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsRecruitingNCT05150691Study sitePhase 1/Phase 2Start 2022-01
  4. SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal MetastasesActive, not recruitingNCT06940921Lead sponsorPhase 1/Phase 2Start 2025-03
  5. The Effect of Environmental Factors on Gastric Cancer Based on MacrogenomeActive, not recruitingNCT06854146Lead sponsorStart 2024-11
  6. Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.Active, not recruitingNCT06641700Lead sponsorStart 2024-10

PubMed searchClinicalTrials.gov

Hepatoblastoma

肝母细胞瘤
2.6%Leads about 1 in 38 of China's research papers on Hepatoblastoma ▲ from 1.2%

Led 4 of 154 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (13.6%).

Run this PubMed search

Open trials led
0
Research papers it led
4
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.9%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 1120242025: 332025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University4

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Retinoblastoma

视网膜母细胞瘤
1.7%Leads about 1 in 60 of China's research papers on Retinoblastoma

Led 5 of 301 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (12.0%).

Run this PubMed search

Open trials led
0
Research papers it led
5
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 3320222023: 0020232024: 1120242025: 112025

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. Second Affiliated Hospital of Chongqing Medical University5
  2. Children's Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Osteosarcoma

骨肉瘤
2.1%Leads about 1 in 47 of China's research papers on Osteosarcoma ▲ from 1.6%

Led 48 of 2,257 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (4.3%).

Run this PubMed search

Open trials led
0
Research papers it led
48
Trials it led
1
Share of China's trials
1.7%
Share of the world's papers
0.9%
Papers led per year
2021: 0020212022: 3320222023: 0020232024: 0020242025: 002025

Over half of these papers are lab or animal studies.

PubMed searchClinicalTrials.gov

Gastrointestinal stromal tumour

胃肠道间质瘤
3.2%Leads about 1 in 31 of China's research papers on Gastrointestinal stromal tumour ▲ from 1.0%

Led 17 of 523 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (6.3%).

Run this PubMed search

Open trials led
1
Research papers it led
17
Trials it led
1
Share of China's trials
1.4%
Share of the world's papers
1.0%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 442025

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University12
  2. Second Affiliated Hospital of Chongqing Medical University4
  3. Third Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.2025CancerRCT
  2. Diagnostic Value of Contrast-Enhanced Ultrasound in Detecting Abdominal Metastases From Gastrointestinal Stromal Tumors.2026Journal of clinical ultrasound : JCU
  3. Development and validation of an ultrasound-based AI-radiomics model for diagnosing and risk-stratifying gastrointestional stromal tumors: a retrospective diagnostic study.2025BMC medical imaging
  4. Gastric Adenocarcinoma Resembling Submucosal Tumor: A Case Report.2025The American journal of case reportsFree full text
  5. Multimodal artificial intelligence for subepithelial lesion classification and characterization: a multicenter comparative study (with video).2025BMC medical informatics and decision making
Trials on ClinicalTrials.gov5
  1. Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GISTRecruitingNCT06507683Lead sponsorN/AStart 2024-05
  2. Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)RecruitingNCT07379047Study sitePhase 2/Phase 3Start 2026-05
  3. A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With ImatinibCompletedNCT04633122Study sitePhase 2Start 2020-11
  4. A Study of CS3007 in Subjects With Gastrointestinal Stromal TumorCompletedNCT04254939Study sitePhase 1/Phase 2Start 2019-08
  5. (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GISTCompletedNCT03465722Study sitePhase 3Start 2018-03

PubMed searchClinicalTrials.gov

Neuroblastoma

神经母细胞瘤
4.9%Leads about 1 in 21 of China's research papers on Neuroblastoma ▲ from 1.6%

Led 55 of 1,132 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.8%).

Run this PubMed search

Open trials led
0
Research papers it led
55
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
1.3%
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 332025

PubMed searchClinicalTrials.gov

Ewing sarcoma

尤文肉瘤
2.5%Leads about 1 in 41 of China's research papers on Ewing sarcoma ▼ from 6.0%

Led 4 of 163 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.6%).

Run this PubMed search

Open trials led
0
Research papers it led
4
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 3320222023: 0020232024: 0020242025: 002025

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University2
  2. Second Affiliated Hospital of Chongqing Medical University1
  3. Children's Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Multiple myeloma

多发性骨髓瘤
0.4%Leads under 1 in 100 of China's research papers on Myeloma

Led 7 of 1,676 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (4.8%).

Run this PubMed search

Open trials led
0
Research papers it led
7
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.08%
Papers led per year
2021: 2220212022: 1120222023: 0020232024: 0020242025: 222025
ThemesStem cell transplantKidney & bone complications

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University4
  2. Second Affiliated Hospital of Chongqing Medical University Counted in the group total2
  3. Clinical Laboratory of Yongchuan Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

B-cell acute lymphoblastic leukaemia (B-ALL)

B 细胞急性淋巴细胞白血病
1.3%Leads about 1 in 75 of China's research papers on B-ALL ▼ from 2.0%

Led 3 of 225 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.9%).

Run this PubMed search

Open trials led
0
Research papers it led
3
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.3%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 332025
ThemesPhiladelphia chromosome & geneticsAntibody & targeted drugsMRD & relapse

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University1
  2. First Affiliated Hospital of Chongqing Medical University Counted in the group total1
  3. Children Hospital, Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Aplastic anaemia

再生障碍性贫血
0.7%Leads under 1 in 100 of China's research papers on Aplastic anaemia

Led 3 of 412 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (17.2%).

Run this PubMed search

Open trials led
0
Research papers it led
3
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 1120212022: 1120222023: 0020232024: 0020242025: 112025
ThemesImmunosuppressive treatment

Hospitals counted here

  1. Second Affiliated Hospital of Chongqing Medical University2
  2. First Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Haemophagocytic lymphohistiocytosis (HLH)

噬血细胞性淋巴组织细胞增生症
2.5%Leads about 1 in 40 of China's research papers on HLH ▲ from 0.5%

Led 10 of 399 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (22.3%).

Run this PubMed search

Open trials led
0
Research papers it led
10
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.6%
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 2220242025: 222025
ThemesGenetics & inherited formsChildrenEBV & infection triggers

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University6
  2. Second Affiliated Hospital of Chongqing Medical University2
  3. First Affiliated Hospital of Chongqing Medical University Counted in the group total1
  4. Chongqing Medical University Affiliated Children's Hospital Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Beta thalassaemia

β 地中海贫血
0.6%Leads under 1 in 100 of China's research papers on Beta thalassaemia

Led 2 of 312 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (9.9%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.1%
Papers led per year
2021: 1120212022: 0020222023: 1120232024: 0020242025: 002025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University1
  2. First Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Haemophilia A

血友病 A
0.4%Leads under 1 in 100 of China's research papers on Haemophilia A New since 2021

Led 1 of 272 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (15.8%).

Run this PubMed search

Open trials led
0
Research papers it led
1
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.04%
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

Hospitals counted here

  1. Second Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Thrombotic thrombocytopenic purpura

血栓性血小板减少性紫癜
3.1%Leads about 1 in 32 of China's research papers on Thrombotic thrombocytopenic purpura New since 2021

Led 2 of 64 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (9.4%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.3%
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 1120242025: 002025

Hospitals counted here

  1. Second Affiliated Hospital of Chongqing Medical University2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Neuromyelitis optica spectrum disorder (NMOSD)

视神经脊髓炎谱系疾病
1.9%Leads about 1 in 54 of China's research papers on NMOSD ▲ from 0.7%

Led 9 of 485 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (10.5%).

Run this PubMed search

Open trials led
0
Research papers it led
9
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.5%
Papers led per year
2021: 0020212022: 1120222023: 1120232024: 2220242025: 112025
ThemesImagingAntibodies & diagnosisBiologic drugs

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University8
  2. Second Affiliated Hospital of Chongqing Medical University Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

IgG4-related disease

IgG4相关性疾病
0.8%Leads under 1 in 100 of China's research papers on IgG4-RD New since 2021

Led 2 of 246 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (19.1%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 1120212022: 1120222023: 0020232024: 0020242025: 002025
ThemesDiagnosis & look-alikes

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led2
  1. Think twice about IgG4-related diseases before operating on hepatic masses.2022Liver international : official journal of the International Association for the Study of the Liver
  2. IgG4-related disease manifesting as scrotal swelling.2021Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

PubMed searchClinicalTrials.gov

Myasthenia gravis

重症肌无力
2.4%Leads about 1 in 42 of China's research papers on Myasthenia gravis New since 2021

Led 12 of 499 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (6.6%).

Run this PubMed search

Open trials led
0
Research papers it led
12
Trials it led
2
Share of China's trials
2.2%
Share of the world's papers
0.5%
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 3320242025: 112025
ThemesCrisis & intensive careAntibodies & diagnosisBiologic & complement drugs

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University10
  2. Children's Hospital of Chongqing Medical University Counted in the group total1
  3. Second Affiliated Hospital of Chongqing Medical University Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. A systematic review of efgartigimod as an effective treatment for myasthenic crisis.2025Naunyn-Schmiedeberg's archives of pharmacology
  2. Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod.2024Frontiers in immunologyFree full text
  3. The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis.2024CNS drugs
  4. Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort study.2024Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
  5. Pediatric myasthenia gravis with a combination of AChR and RyR is associated with an earlier onset and lower CSR rate: A cohort study in southwest China.2023European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Trials on ClinicalTrials.gov6
  1. Myasthenia Gravis Registry in ChinaRecruitingNCT06241521Study siteStart 2024-02
  2. Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia GravisCompletedNCT06707727Lead sponsorStart 2024-07
  3. A Prospective Cohort Study Of Myasthenia GravisStatus unknownNCT04674605Lead sponsorStart 2020-12
  4. A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Active, not recruitingNCT06456580Study sitePhase 3Start 2024-07
  5. A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia GravisActive, not recruitingNCT06298552Study sitePhase 3Start 2024-04
  6. A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia GravisActive, not recruitingNCT06558279Study sitePhase 3Start 2024-09

PubMed searchClinicalTrials.gov

Biliary atresia

胆道闭锁
2.8%Leads about 1 in 36 of China's research papers on Biliary atresia ▲ from 0.8%

Led 6 of 214 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (9.8%).

Run this PubMed search

Open trials led
0
Research papers it led
6
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.8%
Papers led per year
2021: 1120212022: 1120222023: 0020232024: 1120242025: 222025
ThemesLiver transplantDisease mechanismsScreening & diagnosis

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University6

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Anti-NMDA receptor encephalitis

抗 NMDA 受体脑炎
4.2%Leads about 1 in 24 of China's research papers on Anti-NMDA receptor encephalitis ▼ from 5.7%

Led 11 of 264 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (10.2%).

Run this PubMed search

Open trials led
0
Research papers it led
11
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
1.5%
Papers led per year
2021: 0020212022: 2220222023: 1120232024: 0020242025: 222025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University10
  2. First Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Idiopathic pulmonary fibrosis

特发性肺纤维化
0.6%Leads under 1 in 100 of China's research papers on Idiopathic pulmonary fibrosis

Led 6 of 989 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (4.3%).

Run this PubMed search

Open trials led
0
Research papers it led
6
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.1%
Papers led per year
2021: 0020212022: 2220222023: 1120232024: 1120242025: 112025

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University3
  2. Children's Hospital of Chongqing Medical University1
  3. Second Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Amyotrophic lateral sclerosis

肌萎缩侧索硬化症
0.9%Leads under 1 in 100 of China's research papers on Amyotrophic lateral sclerosis New since 2021

Led 7 of 779 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.3%).

Run this PubMed search

Open trials led
0
Research papers it led
7
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.1%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 3320242025: 222025

Hospitals counted here

  1. First Affiliated Hospital of Chongqing Medical University5
  2. Children's Hospital of Chongqing Medical University1
  3. Second Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Spinal muscular atrophy

脊髓性肌萎缩症
1.8%Leads about 1 in 55 of China's research papers on Spinal muscular atrophy New since 2021

Led 1 of 55 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (29.1%).

Run this PubMed search

Open trials led
0
Research papers it led
1
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 112025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Duchenne muscular dystrophy

杜氏肌营养不良
2.8%Leads about 1 in 35 of China's research papers on Duchenne muscular dystrophy New since 2021

Led 6 of 213 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (10.8%).

Run this PubMed search

Open trials led
0
Research papers it led
6
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 0020222023: 2220232024: 0020242025: 332025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University5
  2. First Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Behçet disease

白塞病
12.7%Leads about 1 in 8 of China's research papers on Behçet disease ▼ from 20.7%

Led 31 of 245 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (22.9%).

Run this PubMed search

Open trials led
0
Research papers it led
31
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
2.4%
Papers led per year
2021: 0020212022: 4420222023: 0020232024: 1120242025: 002025

PubMed searchClinicalTrials.gov

IgA nephropathy

IgA 肾病
0.9%Leads under 1 in 100 of China's research papers on IgA nephropathy New since 2021

Led 7 of 736 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (9.4%).

Run this PubMed search

Open trials led
0
Research papers it led
7
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 1120222023: 2220232024: 1120242025: 112025

PubMed searchClinicalTrials.gov

Primary biliary cholangitis

原发性胆汁性胆管炎
0.3%Leads under 1 in 100 of China's research papers on Primary biliary cholangitis New since 2021

Led 1 of 300 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (12.0%).

Run this PubMed search

Open trials led
0
Research papers it led
1
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.1%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 112025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Congenital diaphragmatic hernia

先天性膈疝
6.7%Leads about 1 in 15 of China's research papers on Congenital diaphragmatic hernia New since 2021

Led 4 of 60 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (18.3%).

Run this PubMed search

Open trials led
0
Research papers it led
4
Trials it led
1
Share of China's trials
100.0%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 2220222023: 0020232024: 0020242025: 112025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University4

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Hirschsprung disease

先天性巨结肠
5.0%Leads about 1 in 20 of China's research papers on Hirschsprung disease ▲ from 2.9%

Led 8 of 161 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (13.0%).

Run this PubMed search

Open trials led
0
Research papers it led
8
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
1.1%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 552025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University8

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Inherited epidermolysis bullosa

遗传性大疱性表皮松解症
3.6%Leads about 1 in 28 of China's research papers on Inherited epidermolysis bullosa New since 2021

Led 2 of 56 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (12.5%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 1120222023: 1120232024: 0020242025: 002025

Hospitals counted here

  1. Children's Hospital of Chongqing Medical University1
  2. First Affiliated Hospital of Chongqing Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov